Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences

被引:129
作者
Debela, Mekdes
Magdolen, Viktor
Schechter, Norman
Valachova, Martina
Lottspeich, Friedrich
Craik, Charles S.
Choe, Youngchool
Bode, Wolfram
Goettig, Peter
机构
[1] Max Planck Inst Biochem, Proteinase Res Grp, D-82152 Martinsried, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Frauenklin, Klin Forschergrp, D-81675 Munich, Germany
[3] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[4] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[5] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.M602372200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human tissue kallikreins (hKs) form a family of 15 closely related (chymo) trypsin-like serine proteinases. These tissue kallikreins are expressed in a wide range of tissues including the central nervous system, the salivary gland, and endocrine-regulated tissues, such as prostate, breast, or testis, and may have diverse physiological functions. For several tissue kallikreins, a clear correlation has been established between expression and different types of cancer. For example, the prostate-specific antigen (PSA or hK3) serves as tumor marker and is used to monitor therapy response. Using a novel strategy, we have cloned, expressed in Escherichia coli or in insect cells, refolded, activated, and purified the seven human tissue kallikreins hK3/PSA, hK4, hK5, hK6, hK7, hK10, and hK11. Moreover, we have determined their extended substrate specificity for the nonprime side using a positional scanning combinatorial library of tetrapeptide substrates. hK3/PSA and hK7 exhibited a chymotrypsin-like specificity preferring large hydrophobic or polar residues at the P1 position. In contrast, hK4, hK5, and less stringent hK6 displayed a trypsin-like specificity with strong preference for P1-Arg, whereas hK10 and hK11 showed an ambivalent specificity, accepting both basic and large aliphatic P1 residues. The extended substrate specificity profiles are in good agreement with known substrate cleavage sites but also in accord with experimentally solved ( hK4, hK6, and hK7) or modeled structures. The specificity profiles may lead to a better understanding of human tissue kallikrein functions and assist in identifying their physiological protein substrates as well as in designing more selective inhibitors.
引用
收藏
页码:25678 / 25688
页数:11
相关论文
共 87 条
[1]   Substrate specificity of human kallikrein 6 - Salt and glycosaminoglycan activation effects [J].
Angelo, PF ;
Lima, AR ;
Alves, FM ;
Blaber, SI ;
Scarisbrick, IA ;
Blaber, M ;
Juliano, L ;
Juliano, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (06) :3116-3126
[2]   A novel protease homolog differentially expressed in breast and ovarian cancer [J].
Anisowicz, A ;
Sotiropoulou, G ;
Stenman, G ;
Mok, SC ;
Sager, R .
MOLECULAR MEDICINE, 1996, 2 (05) :624-636
[3]   Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin [J].
Backes, BJ ;
Harris, JL ;
Leonetti, F ;
Craik, CS ;
Ellman, JA .
NATURE BIOTECHNOLOGY, 2000, 18 (02) :187-193
[4]   Managing peptidases in the genomic era [J].
Barrett, AJ ;
Tolle, DP ;
Rawlings, ND .
BIOLOGICAL CHEMISTRY, 2003, 384 (06) :873-882
[5]   Structure of mouse 7S NGF: a complex of nerve growth factor with four binding proteins [J].
Bax, B ;
Blundell, TL ;
MurrayRust, J ;
McDonald, NQ .
STRUCTURE, 1997, 5 (10) :1275-1285
[6]   Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR) [J].
Beaufort, N ;
Debela, M ;
Creutzburg, S ;
Kellermann, J ;
Bode, W ;
Schmitt, M ;
Pidard, D ;
Magdolen, V .
BIOLOGICAL CHEMISTRY, 2006, 387 (02) :217-222
[7]   Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system [J].
Bernett, MJ ;
Blaber, SI ;
Scarisbrick, IA ;
Dhanarajana, P ;
Thomspon, SM ;
Blaber, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) :24562-24570
[8]  
BHOOLA KD, 1992, PHARMACOL REV, V44, P1
[9]   Targeting kallikrein 6-proteolysis attenuates CNS inflammatory disease [J].
Blaber, SI ;
Ciric, B ;
Christophi, GP ;
Bernett, MJ ;
Blaber, M ;
Rodriguez, M ;
Scarisbrick, IA .
FASEB JOURNAL, 2004, 18 (03) :920-+
[10]   Enzymatic properties of rat myelencephalon-specific protease [J].
Blaber, SI ;
Scarisbrick, IA ;
Bernett, MJ ;
Dhanarajan, P ;
Seavy, MA ;
Jin, YH ;
Schwartz, MA ;
Rodriguez, M ;
Blaber, M .
BIOCHEMISTRY, 2002, 41 (04) :1165-1173